Literature DB >> 29288054

Mitochondria in non-alcoholic fatty liver disease.

Inês C M Simões1, Adriana Fontes2, Paolo Pinton3, Hans Zischka4, Mariusz R Wieckowski5.   

Abstract

NAFLD is a common disease in Western society and ranges from steatosis to steatohepatitis and to end-stage liver disease. The molecular mechanisms that cause the progression of steatosis to severe liver damage are not fully understood. One suggested mechanism involves the oxidation of biomolecules by mitochondrial ROS which initiates a vicious cycle of exacerbated mitochondrial dysfunction and increased hepatocellular oxidative damage. This may ultimately pave the way for hepatic inflammation and liver failure. This review updates our current understanding of mitochondria-derived oxidative stress in the progression of NAFLD.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Mitochondria; NAFLD; NASH; ROS; Steatosis

Mesh:

Substances:

Year:  2017        PMID: 29288054     DOI: 10.1016/j.biocel.2017.12.019

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  61 in total

1.  Role of mitochondrial depolarization and disrupted mitochondrial homeostasis in non-alcoholic steatohepatitis and fibrosis in mice.

Authors:  Yasodha Krishnasamy; Monika Gooz; Li Li; John J Lemasters; Zhi Zhong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2019-10-15

Review 2.  Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models.

Authors:  Richard J Weaver; Eric A Blomme; Amy E Chadwick; Ian M Copple; Helga H J Gerets; Christopher E Goldring; Andre Guillouzo; Philip G Hewitt; Magnus Ingelman-Sundberg; Klaus Gjervig Jensen; Satu Juhila; Ursula Klingmüller; Gilles Labbe; Michael J Liguori; Cerys A Lovatt; Paul Morgan; Dean J Naisbitt; Raymond H H Pieters; Jan Snoeys; Bob van de Water; Dominic P Williams; B Kevin Park
Journal:  Nat Rev Drug Discov       Date:  2019-11-20       Impact factor: 84.694

3.  Lipidomics unveils lipid dyshomeostasis and low circulating plasmalogens as biomarkers in a monogenic mitochondrial disorder.

Authors:  Matthieu Ruiz; Alexanne Cuillerier; Caroline Daneault; Sonia Deschênes; Isabelle Robillard Frayne; Bertrand Bouchard; Anik Forest; Julie Thompson Legault; Frederic M Vaz; John D Rioux; Yan Burelle; Christine Des Rosiers
Journal:  JCI Insight       Date:  2019-07-25

4.  The protective effect of selenoprotein M on non-alcoholic fatty liver disease: the role of the AMPKα1-MFN2 pathway and Parkin mitophagy.

Authors:  Jingzeng Cai; Jiaqiang Huang; Jie Yang; Xiaoming Chen; Haoran Zhang; Yue Zhu; Qi Liu; Ziwei Zhang
Journal:  Cell Mol Life Sci       Date:  2022-06-09       Impact factor: 9.261

Review 5.  Phytochemicals targeting NAFLD through modulating the dual function of forkhead box O1 (FOXO1) transcription factor signaling pathways.

Authors:  Usman Sabir; Hafiz Muhammad Irfan; Ihtisham Umer; Zahid Rasul Niazi; Hafiz Muhammad Mazhar Asjad
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-03-31       Impact factor: 3.000

Review 6.  Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC.

Authors:  Hyunmi Kim; Da Som Lee; Tae Hyeon An; Hyun-Ju Park; Won Kon Kim; Kwang-Hee Bae; Kyoung-Jin Oh
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

7.  One Week of CDAHFD Induces Steatohepatitis and Mitochondrial Dysfunction with Oxidative Stress in Liver.

Authors:  Takehito Sugasawa; Seiko Ono; Masato Yonamine; Shin-Ichiro Fujita; Yuki Matsumoto; Kai Aoki; Takuro Nakano; Shinsuke Tamai; Yasuko Yoshida; Yasushi Kawakami; Kazuhiro Takekoshi
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

Review 8.  Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review.

Authors:  Raquel Cano; José L Pérez; Lissé Angarita Dávila; Ángel Ortega; Yosselin Gómez; Nereida Josefina Valero-Cedeño; Heliana Parra; Alexander Manzano; Teresa Isabel Véliz Castro; María P Díaz Albornoz; Gabriel Cano; Joselyn Rojas-Quintero; Maricarmen Chacín; Valmore Bermúdez
Journal:  Int J Mol Sci       Date:  2021-05-01       Impact factor: 5.923

9.  DHA Protects Hepatocytes from Oxidative Injury through GPR120/ERK-Mediated Mitophagy.

Authors:  Jinglong Chen; Danping Wang; Yibo Zong; Xiaojing Yang
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

Review 10.  Protocols for Mitochondria as the Target of Pharmacological Therapy in the Context of Nonalcoholic Fatty Liver Disease (NAFLD).

Authors:  Ignazio Grattagliano; Agostino Di Ciaula; Jacek Baj; Emilio Molina-Molina; Harshitha Shanmugam; Gabriella Garruti; David Q-H Wang; Piero Portincasa
Journal:  Methods Mol Biol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.